2oi4: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2oi4.gif|left|200px]] | [[Image:2oi4.gif|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_2oi4", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
| | --> | ||
| | {{STRUCTURE_2oi4| PDB=2oi4 | SCENE= }} | ||
}} | |||
'''Crystal structure of human PIM1 in complex with fluorinated ruthenium pyridocarbazole''' | '''Crystal structure of human PIM1 in complex with fluorinated ruthenium pyridocarbazole''' | ||
Line 28: | Line 25: | ||
[[Category: Maksimoska, J.]] | [[Category: Maksimoska, J.]] | ||
[[Category: Meggers, E.]] | [[Category: Meggers, E.]] | ||
[[Category: | [[Category: Atp-binding,phosphorylation]] | ||
[[Category: | [[Category: Transferase,pim1,kinase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 10:58:22 2008'' | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on |
Revision as of 10:58, 4 May 2008
Crystal structure of human PIM1 in complex with fluorinated ruthenium pyridocarbazole
OverviewOverview
A general route to ruthenium pyridocarbazole half-sandwich complexes is presented and applied to the synthesis of sixteen new compounds, many of which have modulated protein kinase inhibition properties. For example, the incorporation of a fluorine into the pyridine moiety increases the binding affinity for glycogen synthase kinase 3 by almost one order of magnitude. These data are supplemented with cyclic voltammetry experiments and a protein co-crystallographic study.
About this StructureAbout this Structure
2OI4 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
Ruthenium half-sandwich complexes as protein kinase inhibitors: derivatization of the pyridocarbazole pharmacophore ligand., Pagano N, Maksimoska J, Bregman H, Williams DS, Webster RD, Xue F, Meggers E, Org Biomol Chem. 2007 Apr 21;5(8):1218-27. Epub 2007 Mar 20. PMID:17406720 Page seeded by OCA on Sun May 4 10:58:22 2008